Charles (Chuck) Kummeth
President and Chief Executive Officer
Chuck Kummeth became President and Chief Executive Officer of Bio-Techne Corporation on April 1, 2013. Prior to joining the Company, he served as President of Mass Spectrometry and Chromatography at Thermo Fisher Scientific Inc. and was President of that company’s Laboratory Consumables Division from 2009 to September 2011. Prior to joining Thermo Fisher, Mr. Kummeth served in various leadership roles during his 24 year career at 3M Corporation, most recently as the Vice President of the company’s Medical Division from 2006 to 2008 and as the Managing Director of 3M for the UK and Ireland.
Mr. Kummeth received a Master of Science in Software Engineering & Design from the University of St. Thomas and a Master of Business Administration from the Carlson School of Business at the University of Minnesota. He is a graduate of the University of North Dakota, where he received a Bachelor of Science in Electrical Engineering. Mr. Kummeth serves on the board of Gentherm.
Executive Vice President - Chief Financial Officer
James T. Hippel became Chief Financial Officer on April 1, 2014. Prior to joining the Company, he served as Senior Vice President and CFO for Mirion Technologies, Inc., a $300 million global technology and manufacturing company which provides mission critical products to detect, monitor and identify radiation. Prior to Mirion, Mr. Hippel served as Vice President, Finance at Thermo Fisher Scientific, Inc., leading finance operations for its $2 billion Mass Spectrometry & Chromatography and $1 billion Laboratory Consumables divisions. Mr. Hippel's experience also includes nine years of progressive financial leadership at Honeywell International, within its Aerospace Segment. He began his career with KPMG Peat Marwick LLP.
Mr. Hippel holds a Master of Business Administration from Arizona State University and a Bachelor of Accountancy degree from Northern Arizona University. He is also a CPA (inactive).
President, Protein Sciences Segment
Dave Eansor was appointed President of the Protein Sciences Segment in July 2018. Prior to that, Mr. Eansor was the Senior Vice President of the Biotech Division. Mr. Eansor joined Bio-Techne through the acquisition of Novus Biologicals in July 2014. Prior to joining Novus Biologicals in 2013, Mr. Eansor was the President of the ~$1 Billion Bioscience Division of Thermo Fisher Scientific. Mr. Eansor was promoted to Division President in early 2010 after 5 years as President of Thermo Fisher's Life Science Research business. Prior to joining Thermo Fisher Scientific, Mr. Eansor spent 5 years as President of Cambrex Bioproducts. Prior to joining Cambrex, Mr. Eansor spent 19 years with R. P. Scherer Corporation, a contract pharmaceutical drug delivery manufacturer which was acquired by Cardinal Health and later Catalent. There he held various senior management positions, the last of which was Vice President of Pharmaceutical Operations.
Mr. Eansor has a Bachelor of Science in Chemistry from University of Western Ontario, a Bachelor of Commerce in General Business and Economics, and a Master of Business Administration from the University of Windsor, Ontario, Canada.
President, Diagnostics and Genomics
Kim Kelderman joined Bio-Techne on April 30, 2018 as President, Diagnostics and Genomics. Prior to Bio-Techne, Mr. Kelderman was employed at Thermo Fisher Scientific where he led three different businesses of increasing scale and complexity. For the last three years, Mr. Kelderman managed the Platforms and Content of the Genetic Sciences Division, where he was responsible for the Instrumentation, Software, Consumables and Assays businesses, and brands such as Applied Biosystems and legacy Affymetrix. Before joining Thermo Fisher, Kim served as Senior Segment Leader at Becton Dickinson, managing the global Blood Tubes "Vacutainer" business.
Mr. Kelderman holds a Bachelor of Science degree from Hogeschool Heerlen of Applied Sciences in the Netherlands.
Executive Vice President - General Counsel, Secretary and Chief Compliance Officer
Brenda Furlow joined the Company as Senior Vice President and General Counsel in August 2014. Before joining the Company, Ms. Furlow was affiliated with Alphatech Counsel, SC and served as general counsel to emerging growth technology companies. From 2007 to 2011, Ms. Furlow was General Counsel for TomoTherapy, Inc., a global, publicly traded company that manufactured and sold radiation therapy equipment, and from 1998 to 2007, she was General Counsel for Promega Corporation, a global life sciences company.
Ms. Furlow holds a Juris Doctor degree from University of Chicago Law School.
Vice President - APAC
Peter Breloer joined Bio-Techne on August 1, 2015 as Vice President of Asia-Pacific based in Hong Kong. Prior to Bio-Techne, Mr. Breloer was employed at Thermo Fisher Scientific APAC where he led the Laboratory Consumables business 2010-2011, resp. Chromatography & Mass Spectrometry business 2012 – July 2015. Before joining Thermo Fisher Scientific, Peter served 20 years in 3M Company with increasing scale and complexity incl. General Manager Energy & Advanced Materials APAC resp. EMEA roles & European business head Electronics Markets Materials. Prior 3M he was with TUEV-Rheinland’s Equipment Safety Division Japan & Taiwan 1987-1988.
Mr. Breloer holds a Dipl.-Ing. Applied Physics degree from Germany, with specialty on solid state physics (1986).
Vice President – Quality and Regulatory
Qi Cheng became Vice President of Quality & Regulatory on July 27th, 2021. Mrs. Cheng held various management positions at Bio-Techne from Technical Service, Quality Control, Senior Director of Product Support/Process Improvement and Senior Director of Quality. Mrs. Cheng has in-depth knowledge of many Bio-Techne products and understand customers’ quality & regulatory needs. She is a Certified Manager of Quality/Organizational Excellence from American Society for Quality since 2013.
Mrs. Cheng attended Shanghai Jiao Tong University School of Medicine and North Dakota State University when she received Ph.D. in Molecular and Cellular Biology. She served as NIH postdoctoral Fellow at Pediatric Infectious Disease Division from University of Minnesota School of Medicine.
Vice President - Analytical Solutions Division
Steve Crouse joined Bio-Techne in March 2021 as the Vice President, Analytical Solutions Development, responsible for Bio-Techne’s ProteinSimple branded products and R&D Systems Immunoassays portfolio. Steve has >20 years of experience leading R&D, Business Development, Marketing and Sales organizations. Most recently he was the Sr. Director and General Manager for the Protein Detection and Quantification business unit at Thermo Fisher Scientific. Prior to that he held positions as the Chief Operating Officer at Vortex Biosciences and the Sr. Vice President of Sales and Marketing at Freeslate Inc., which was sold to Unchained Labs in 2016. Previously, Steve held several marketing, sales, and R&D leadership roles with Bio-Rad Laboratories and Life Technologies (now Thermo Fisher Scientific). He has an MBA from the Marshall School of Business at the University of Southern California and a M.S. in Biochemistry from Georgetown University.
Senior Vice President – Reagent Solutions Division
Michael Deines joined Bio-Techne in May 2020 as Vice President, Reagent Solutions Division bringing over 30 years of Life Science industry leadership experience to his role. Prior to joining Bio-Techne, he served as General Manager, Environmental and Analytical Reagents. Previously, he served as Vice President, Sales and Marketing for Thermo Fisher Scientific’s $1 billion Bioscience Division and Vice President, Biotechnology Sales at Sigma-Aldrich. Mr. Deines also held Sales and Marketing Management roles at Amersham Biosciences.
His technical background includes molecular biology research at University of Colorado Health Sciences Center and a Bachelor of Arts in Chemistry from University of Colorado, Boulder.
Vice President – Corporate Development
Bob Gavin was appointed as the Senior Vice President of the Analytical Solutions Division in August 2018. Mr. Gavin joined Bio-Techne with the acquisition of ProteinSimple in 2014, where he was Vice President of Product Development. Mr. Gavin has more than twenty-five years of experience in the Life Science tools industry, previously serving as Director of Engineering at Molecular Devices for nine years after starting in the field at Affymax Research Institute.
Mr. Gavin holds a Bachelor of Science in Mechanical Engineering and a Master of Science in Manufacturing Systems Engineering from Stanford University.
Senior Vice President – Diagnostic Reagents Division
Kevin Gould joined Bio-Techne in July 2015 with the acquisition of Cliniqa Corporation. Mr. Gould had been President and Chief Executive Officer of Cliniqa from April 2006. Prior to that Mr. Gould was Vice President and General Manager of Seracare Life Sciences’ BBI Diagnostics business. From January 1999 to December 2004 he was Vice President Sales and Marketing of Fisher Scientific/Medical Analysis Systems Inc.(now Thermo Fisher Scientific) Clinical Diagnostics division. Prior to that he held various management positions with Biopool International (now Diagnostica Stago) and Curtin Matheson Scientific (now Thermo Fisher Scientific).
Mr. Gould holds a Bachelors Degree in Business Administration from California Lutheran University.
Vice President – Human Resources
Struan Robertson joined Bio-Techne in August 2015 as Vice President of Human Resources, Integration and Transformation. Prior to joining Bio-Techne, he founded and lead a boutique management consultancy for 12 years in London, UK specializing in organizational change and performance improvement. Struan has authored two books, ‘BE-a-TEN at Change’ and ‘Lower your life handicap’.
Vice President – Exosome Diagnostics
Steven M. Silverman became Vice President and General Manager of the Exosome Diagnostics business in January 2019. Prior to joining the Company, Mr. Silverman served as Vice President of Global Marketing for the Life Science Group of Thermo Fisher Scientific. Steve’s experience also includes twenty-seven years of progressive general management, marketing and commercial experience within Thermo Fisher Scientific and over thirty years within the Life Science industry in total.
Mr. Silverman holds a Bachelor of Science degree from the University of Vermont and attended the Advanced Management Program at INSEAD.
Senior Vice President - Chief Digital Officer
Kevin Smyth joined Bio-Techne on January 8, 2018 as the Chief Digital Officer. Prior to that, Mr. Smyth was Vice President of Commercial Digital Solutions at Ecolab, a global leader in water, hygiene and infection prevention solutions and services. From 2007 to 2010, Mr. Smyth was the Chief Information Officer at Cerner Corporation, a health care information technology solutions supplier.
Mr. Smyth has a Bachelor of Science in Mechanical Engineering from California State Polytechnic University, Pomona and a Master of Science in Mechanical Engineering from California State University, Fullerton.
Vice President – EMEA
Gary Stapleton became Vice President of Bio-Techne Corporation EMEA on July 1, 2016. Prior to joining the Company, he served in various positions at 3M over a 26-year career culminating as Director of 3M Health Care EMEA from 2013 to 2015, as well as, Managing Director of 3M’s operations in Australia and New Zealand from 2011 to 2013. Prior to joining 3M Mr. Stapleton worked at BDO Stoy Hayward in London, where he qualified as a Chartered Accountant and remains a Fellow of the Institute of Chartered Accountants in England and Wales.
Mr. Stapleton received a Bachelor of Finance and Accounting from the City of London Polytechnic. Mr. Stapleton has served on a number of industry boards including the Association of British Health Tech Industries (ABHI) and Medilink UK where he served in the capacity of Chairman.
Vice President – Genomics
Kamni Vijay joined Bio-Techne in July 2019 as Vice President of the Genomics division. Dr. Vijay has over twenty years of experience in product development across the Life Sciences industry. Prior to joining Bio-Techne, she served as Vice President and General Manager for Genomics at Agilent Technologies. There she pioneered Agilent’s efforts to develop an integrated clinical workflow solution in Genomics, to combine genome-based insights with data analytics to enable personalized medicine. In addition, she served on the Board of Directors at Lasergen, a next generation sequencing company. Dr. Vijay previously led the product marketing efforts for Agilent’s Software Informatics portfolio, serving the chromatography, mass spectrometry and spectroscopy markets. Prior to Agilent, she served in leadership positions across a number of growth portfolios at Bio-Rad Laboratories. She worked to establish the company’s footprint in genomics and drove the relaunch of the company’s chromatography portfolio, receiving numerous industry accolades for bespoken marketing activities.
Dr. Vijay volunteers as a District Enrollment Director for undergraduate admissions at Dartmouth College, and is an active member in the G100 Women’s Leadership Network. She earned a Bachelor of Arts in Biochemistry and Minor in Art History from Dartmouth College, and served as a NIH pre-doctoral fellow at University of California Davis where she received her PhD in Microbiology.